Michio Kogame
Overview
Explore the profile of Michio Kogame including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wakui N, Nagai H, Matsukiyo Y, Ogino Y, Matsui D, Mukozu T, et al.
Ultrasound Q
. 2018 Apr;
34(3):128-132.
PMID: 29634669
Arrival time parametric imaging (At-PI) in contrast-enhanced ultrasonography is useful for assessing liver fibrosis in chronic hepatitis C (CHC) infection. The study aimed to elucidate the effect of hepatic inflammation...
2.
Shiozawa K, Watanabe M, Ikehara T, Matsukiyo Y, Kogame M, Kikuchi Y, et al.
J Clin Ultrasound
. 2016 Nov;
45(3):138-144.
PMID: 27861987
Purpose: To compare contrast-enhanced ultrasonography (CEUS) using Sonazoid with Gd-EOB-DTPA-enhanced MRI (EOB-MRI) in the diagnosis of liver metastases in patients with colorectal cancer. Methods: A total of 69 patients diagnosed...
3.
Kogame M, Nagai H, Shinohara M, Igarashi Y, Sumino Y, Ishii K
Anticancer Res
. 2016 Sep;
36(9):4529-36.
PMID: 27630292
Background/aim: It has been reported that type 2 helper T-cell (Th2) cytokines down-regulate antitumor immunity, while Th1 cytokines up-regulate it. We previously reported that hepatocarcinogenesis was associated with Th2 dominance...
4.
Momiyama K, Nagai H, Ogino Y, Mukouzu T, Matsui D, Kogame M, et al.
Clin Cancer Drugs
. 2016 Sep;
2(2):112-118.
PMID: 27595062
Purpose: We have previously reported that continuous hepatic arterial infusion chemotherapy (HAIC) might be more effective for advanced hepatocellular carcinoma (aHCC) in patients with liver cirrhosis (LC) related to HCV...
5.
Shiozawa K, Watanabe M, Ikehara T, Matsukiyo Y, Kogame M, Shinohara M, et al.
Gan To Kagaku Ryoho
. 2016 Jul;
43(7):863-7.
PMID: 27431630
We examined plasma biomarkers as predictive factors for advanced hepatocellular carcinoma(ad-HCC)patients treated with sorafenib. We analyzed a-fetoprotein(AFP), AFP-L3, des-g-carboxy prothrombin(DCP), neutrophil-to-lymphocyte ratio(NLR), platelet-to-lymphocyte ratio(PLR), and vascular endothelial growth factor(VEGF)before sorafenib...
6.
Shiozawa K, Watanabe M, Ikehara T, Kogame M, Kikuchi Y, Igarashi Y, et al.
Oncol Lett
. 2016 Jun;
12(1):579-584.
PMID: 27347183
The present study aimed to determine the usefulness of contrast-enhanced ultrasonography (CEUS) with Sonazoid in evaluating the therapeutic response to sorafenib for hepatocellular carcinoma (HCC). In total, 26 patients with...
7.
Shiozawa K, Watanabe M, Ikehara T, Matsukiyo Y, Kogame M, Shinohara M, et al.
Gan To Kagaku Ryoho
. 2016 Apr;
43(2):215-8.
PMID: 27067685
We aimed to determine the usefulness of arrival time parametric imaging (AtPI) using contrast-enhanced ultrasonography (CEUS)with Sonazoid in the evaluation of early response to sorafenib for hepatocellular carcinoma (HCC). Thirteen...
8.
Shiozawa K, Watanabe M, Ikehara T, Matsukiyo Y, Kogame M, Kishimoto Y, et al.
World J Gastroenterol
. 2016 Jan;
21(48):13490-9.
PMID: 26730160
Aim: To compare therapeutic outcomes and adverse events in initial solitary hepatocellular carcinoma (HCC) treated with radiofrequency ablation (RFA) and CyberKnife(®). Methods: Seventy three consecutive patients with initial solitary HCC...
9.
Shiozawa K, Watanabe M, Ikehara T, Matsukiyo Y, Kogame M, Okano N, et al.
Gan To Kagaku Ryoho
. 2015 Sep;
42(8):953-6.
PMID: 26321708
We compared the benefits of sorafenib with that of hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma (ad-HCC) refractory to transcatheter arterial chemoembolization (TACE). We evaluated the patient characteristics,...
10.
Shiozawa K, Watanabe M, Ikehara T, Kogame M, Matsui T, Okano N, et al.
Hepatogastroenterology
. 2015 Jul;
61(132):885-91.
PMID: 26158136
Background/aims: This prospective non-randomized controlled trial aimed to compare the efficacy of sorafenib vs hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma. Methodology: Forty-seven patients treated with sorafenib (sorafenib...